Method for identifying type-1 interferon responsive ms patients by determining trail expression

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20070077557A1
SERIAL NO

10513312

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to a method for identifying MS patients susceptible to type I-Interferon (IFN), in particular IFN-.beta., and for monitoring IFN therapy in MS patients by determining TRAIL gene and/or protein expression as a marker.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHARITE - UNIVERSITATSMEDIZIN BERLINCHARITÉPLATZ1 BERLIN 10117

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lunemann, Jan Berlin, DE 1 0
Wandinger, Klaus-Peter Berlin, DE 1 0
Zipp, Frauke Berlin, DE 3 13

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation